Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-11-003003
Filing Date
2011-03-31
Accepted
2011-03-31 16:58:23
Documents
7
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2203096z10-k.htm 10-K 1422469
2 EX-21.1 a2203096zex-21_1.htm EX-21.1 2015
3 EX-23 a2203096zex-23.htm EX-23 3039
4 EX-31.1 a2203096zex-31_1.htm EX-31.1 7844
5 EX-31.2 a2203096zex-31_2.htm EX-31.2 7886
6 EX-32.1 a2203096zex-32_1.htm EX-32.1 4317
7 EX-32.2 a2203096zex-32_2.htm EX-32.2 4344
  Complete submission text file 0001047469-11-003003.txt   1453028
Mailing Address 420 LEXINGTON AVENUE SUITE 601 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 601 NEW YORK NY 10170 2126729190
CALLISTO PHARMACEUTICALS INC (Filer) CIK: 0001142380 (see all company filings)

EIN.: 651107840 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-32325 | Film No.: 11727142
SIC: 2834 Pharmaceutical Preparations